Problems in selection of topical anti-inflammatory corticosteroids

Area of Science:

• Dermatology
• Pharmacology
• Medicinal Chemistry

Background:

• Topical corticosteroids are widely used for anti-inflammatory purposes.
• The role of fluorination in enhancing corticosteroid potency has been a key area of research.
• Desonide is a non-fluorinated topical corticosteroid, while triamcinolone acetonide is a fluorinated analogue.

Purpose of the Study:

• To compare the vasoconstriction ability and epidermal penetration rate of desonide with triamcinolone acetonide.
• To assess the clinical effectiveness of desonide against a potent fluorinated steroid, betamethasone 17-valerate.
• To determine if steroid molecule fluorination is essential for potent topical anti-inflammatory effects.

Main Methods:

• Vasoconstriction assays were performed to compare desonide and triamcinolone acetonide.
• Epidermal penetration rates were measured for both compounds.
• A double-blind paired comparison study was conducted using desonide and betamethasone 17-valerate.

Main Results:

• Fluorination of the steroid molecule did not enhance vasoconstriction ability or epidermal penetration rate in the studied drugs.
• Desonide demonstrated comparable clinical effectiveness to betamethasone 17-valerate in a double-blind paired comparison.
• The anti-inflammatory effect of topical corticosteroids can be achieved without molecular fluorination.

Conclusions:

• Potent topical anti-inflammatory effects can be achieved with non-fluorinated corticosteroids like desonide.
• Fluorination does not appear to be a critical factor for enhancing vasoconstriction or epidermal penetration of these topical steroids.
• Desonide represents a viable therapeutic option with efficacy comparable to potent fluorinated corticosteroids.